Skip Navigation Archive: U.S. Department of Health and Human Services U.S. Department of Health and Human Services
Archive: Agency for Healthcare Research Quality
Archival print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

  • Publication # 13-RA004

The March 2014 issue of Research Activities was the last issue of the monthly newsletter. AHRQ is transitioning to a new quarterly thematic publication that will provide longer, more in-depth analyses of individual topics related to AHRQ’s four priority areas. This new publication will be available online  in the Fall.

Research Activities readers will still be able to access published studies by AHRQ and AHRQ-supported researchers on the AHRQ Research Studies Web page, which will be online later this Spring. Studies can be accessed by first author, publication date, and key word.

Thanks to all our readers over the years who have told us how much they have enjoyed the newsletter. We hope our new quarterly publication will be equally useful in learning more about AHRQ and the field of health services research!

For questions, please contact Research Activities managing editor, Gail Makulowich, at or at 301-427-1711.

Elderly colon cancer patients receiving chemotherapy after surgery are at risk for various toxicities

Elderly Health/Long-Term Care

Patients who receive surgery for stage III colon cancer can benefit from 5-flurouracil (5-FU)-based chemotherapy. However, 5-FU-based chemotherapy is associated with increased risk of developing gastrointestinal (GI), blood, and cardiac toxicities in elderly patients with colon cancer. These patients need to be closely monitored so that the benefits of chemotherapy can outweigh the risks, suggest the study authors. They identified 12,099 patients with stage III colon cancer from a Medicare database. Of these, 4,359 did not receive any chemotherapy following surgery, with the remaining 7,740 (63.9 percent) getting 5-FU-based chemotherapy within 3 months after tumor resection. Researchers calculated the 3-month cumulative incidence rate for GI and blood toxicities and risk for heart disease.

Patients receiving chemotherapy were more likely to be younger, married, and have fewer coexisting conditions than the untreated group. This difference was most pronounced for age, with 88.2 percent of patients aged 65 to 69 initiating chemotherapy compared to just 18.1 percent of patients aged 85 and older. During 3 months after surgery, the cumulative incidence rate of toxicities was 9.1 percent in the chemotherapy group and 4.3 percent in the non-chemotherapy group. Common toxicities included volume depletion disorder, agranulocytosis (potentially lethal reduction in the number of white blood cells), diarrhea, nausea, and vomiting. Women were 35 percent more likely to experience toxicities than men and blacks were 35 percent less likely to develop toxicities than whites. Chemotherapy was only slightly associated with the risk for developing heart disease. The study was supported by the Agency for Healthcare Research and Quality (HS16743).

See "Adjuvant chemotherapy and risk of gastrointestinal, hematologic, and cardiac toxicities in elderly patients with stage III colon cancer," by Chung-Yuan Hu, PhD, Wenyaw Chan, PhD, George P. Declos, MD, PhD, and Xianglin L. Du, MD, PhD, in the June 2012 American Journal of Clinical Oncology 35(3), pp. 228-236.


Page last reviewed January 2013
Internet Citation: Elderly colon cancer patients receiving chemotherapy after surgery are at risk for various toxicities: Elderly Health/Long-Term Care. January 2013. Agency for Healthcare Research and Quality, Rockville, MD.


The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care